PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – has completed its acquisition of Ajinomoto Althea, Inc. (“Althea”), a US-based sterile fill-finish CDMO and subsidiary of Japan-based Ajinomoto Co., Inc. For PCI, the acquisition is a cornerstone of a multi-year investment strategy spanning facilities in the United States and Europe. In the United States, Althea’s assets combine with PCI’s existing sterile fill-finish and advanced drug delivery operations to form a world-class, large-scale manufacturing hub in San Diego, complete with state-of-the-art large-scale aseptic facilities for prefilled syringes and cartridges.
Read the full article: PCI Pharma Services Completes Acquisition of Ajinomoto Althea //
Source: https://www.businesswire.com/news/home/20250501652991/en/Part-of-%241-Billion-Investment-Strategy-PCI-Pharma-Services-Completes-Acquisition-of-Ajinomoto-Althea-Enhancing-US-Drug-Product-Manufacturing-for-Aseptic-Filling-of-Prefilled-Syringes-Cartridges